Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity

Cancer Research

Volumn 61, Issue 2, 2001, Pages 694-699

  Guillemard, V ^a   Saragovi, H U ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MC192; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONJUGATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; FEMALE; MOUSE; NEUROECTODERM TUMOR; NONHUMAN; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOCONJUGATES; KINETICS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PACLITAXEL; PROTEIN BINDING; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; SENSITIVITY AND SPECIFICITY; SOLUBILITY; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035862692     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent from Taxus brevifolia
2. Promotion of microtubule assembly in vitro by Taxol
3. Taxol (paclitaxel) was approved by FDA for the treatment of patients with recurrent ovarian cancer
4. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents
5. Chemotherapeutic neuropathy
6. HER-2/neu protein: A target for antigen-specific immunotherapy of human cancer
7. Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck
8. Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors
9. In vitro and in vivo evaluation of human tumor necrosis factor-α (hTNFα) chemically conjugated to monoclonal antibody
10. Small molecule nerve growth factor analogs image receptors in vivo
11. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
12. The trk proto-oncogene product: A signal transducing receptor for nerve growth factor
13. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
14. Development of pharmacological agents for targeting neurotrophins and their receptors
15. A monoclonal antibody modulates the interaction of nerve growth factor with PC12 cells
16. Potent human pl40-TrkA agonists derived from an anti-receptor monoclonal antibody
17. Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of Taxol with potent antitumor activity
18. L Capping and internalization of a monoclonal antibody-surface antigen complex: A possible mode of interaction of monoclonal antibodies and tumor cells
19. Constitutive N-myc gene expression inhibits trkA mediated neuronal differentiation
20. Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands
21. Taxol: The chemistry and structure-activity relationships of a novel anticancer agent
22. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75
23. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy
24. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors